These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31601050)

  • 1. Mixed-Generation PAMAM G3-G0 Megamer as a Drug Delivery System for Nimesulide: Antitumor Activity of the Conjugate Against Human Squamous Carcinoma and Glioblastoma Cells.
    Zaręba M; Sareło P; Kopaczyńska M; Białońska A; Uram Ł; Walczak M; Aebisher D; Wołowiec S
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31601050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular uptake of glucoheptoamidated poly(amidoamine) PAMAM G3 dendrimer with amide-conjugated biotin, a potential carrier of anticancer drugs.
    Uram Ł; Szuster M; Filipowicz A; Zaręba M; Wałajtys-Rode E; Wołowiec S
    Bioorg Med Chem; 2017 Jan; 25(2):706-713. PubMed ID: 27919613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and Different Effects of Biotinylated PAMAM G3 Dendrimer Substituted with Nimesulide in Human Normal Fibroblasts and Squamous Carcinoma Cells.
    Uram Ł; Filipowicz-Rachwał A; Misiorek M; Winiarz A; Wałajtys-Rode E; Wołowiec S
    Biomolecules; 2019 Sep; 9(9):. PubMed ID: 31480608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biotin Transport-Targeting Polysaccharide-Modified PAMAM G3 Dendrimer as System Delivering α-Mangostin into Cancer Cells and
    Markowicz J; Uram Ł; Wołowiec S; Rode W
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Biotinylated PAMAM G3 Dendrimers Conjugated with COX-2 Inhibitor (celecoxib) and PPARγ Agonist (Fmoc-L-Leucine) on Human Normal Fibroblasts, Immortalized Keratinocytes and Glioma Cells in Vitro.
    Uram Ł; Misiorek M; Pichla M; Filipowicz-Rachwał A; Markowicz J; Wołowiec S; Wałajtys-Rode E
    Molecules; 2019 Oct; 24(20):. PubMed ID: 31652556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vitro Evaluation of Third Generation PAMAM Dendrimer Conjugates.
    Najlah M; Freeman S; Khoder M; Attwood D; D'Emanuele A
    Molecules; 2017 Oct; 22(10):. PubMed ID: 28976921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biotinylated PAMAM G3 dendrimer conjugated with celecoxib and/or Fmoc-l-Leucine and its cytotoxicity for normal and cancer human cell lines.
    Uram Ł; Filipowicz A; Misiorek M; Pieńkowska N; Markowicz J; Wałajtys-Rode E; Wołowiec S
    Eur J Pharm Sci; 2018 Nov; 124():1-9. PubMed ID: 30118847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of Biotinylated PAMAM G3 Dendrimers Substituted with
    Wróbel K; Wołowiec S; Markowicz J; Wałajtys-Rode E; Uram Ł
    Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and Properties of α-Mangostin and Vadimezan Conjugates with Glucoheptoamidated and Biotinylated 3rd Generation Poly(amidoamine) Dendrimer, and Conjugation Effect on Their Anticancer and Anti-Nematode Activities.
    Markowicz J; Wołowiec S; Rode W; Uram Ł
    Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35335982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified Carboxyl-Terminated PAMAM Dendrimers as Great Cytocompatible Nano-Based Drug Delivery System.
    Vu MT; Bach LG; Nguyen DC; Ho MN; Nguyen NH; Tran NQ; Nguyen DH; Nguyen CK; Hoang Thi TT
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31022905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and in vitro characterization of pluronic-attached polyamidoamine dendrimers for drug delivery.
    Gu Z; Wang M; Fang Q; Zheng H; Wu F; Lin D; Xu Y; Jin Y
    Drug Dev Ind Pharm; 2015 May; 41(5):812-8. PubMed ID: 24745851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronic acid-nimesulide conjugates as anticancer drugs against CD44-overexpressing HT-29 colorectal cancer in vitro and in vivo.
    Jian YS; Chen CW; Lin CA; Yu HP; Lin HY; Liao MY; Wu SH; Lin YF; Lai PS
    Int J Nanomedicine; 2017; 12():2315-2333. PubMed ID: 28392690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro cytotoxicity of the ternary PAMAM G3-pyridoxal-biotin bioconjugate.
    Uram Ł; Szuster M; Gargasz K; Filipowicz A; Wałajtys-Rode E; Wołowiec S
    Int J Nanomedicine; 2013; 8():4707-20. PubMed ID: 24376351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug delivery investigations of quaternised poly(propylene imine) dendrimer using nimesulide as a model drug.
    Murugan E; Geetha Rani DP; Yogaraj V
    Colloids Surf B Biointerfaces; 2014 Feb; 114():121-9. PubMed ID: 24184533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel PAMAM G3 Dendrimer-Based Foam with Polyether Polyol and Castor Oil Components as Drug Delivery System into Cancer and Normal Cells.
    Zaręba M; Chmiel-Szukiewicz E; Uram Ł; Noga J; Rzepna M; Wołowiec S
    Materials (Basel); 2024 Aug; 17(16):. PubMed ID: 39203083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conjugation of Phthalocyanine Photosensitizer with Poly(amidoamine) Dendrimer: Improved Solubility, Disaggregation and Photoactivity Against HepG2 Cells.
    Jiang Z; Ye J; Yang J; Wang J; Jia L; Ho RJ
    Curr Cancer Drug Targets; 2019; 19(4):312-320. PubMed ID: 29984658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chiral Recognition of Homochiral Poly (amidoamine) Dendrimers Substituted with
    Malinga-Drozd M; Uram Ł; Wróbel K; Wołowiec S
    Polymers (Basel); 2021 Mar; 13(7):. PubMed ID: 33801610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial Surface Modification of Low Generation Polyamidoamine Dendrimers: Gaining Insight into their Potential for Improved Carboplatin Delivery.
    Nguyen DH; Bach LG; Nguyen Tran DH; Cao VD; Nguyen TNQ; Le TTH; Tran TT; Thi TTH
    Biomolecules; 2019 Jun; 9(6):. PubMed ID: 31159469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of G3 PAMAM dendrimer conjugated with B-group vitamins on cell morphology, motility and ATP level in normal and cancer cells.
    Uram Ł; Szuster M; Misiorek M; Filipowicz A; Wołowiec S; Wałajtys-Rode E
    Eur J Pharm Sci; 2017 May; 102():275-283. PubMed ID: 28323116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sugar Modification Enhances Cytotoxic Activity of PAMAM-Doxorubicin Conjugate in Glucose-Deprived MCF-7 Cells - Possible Role of GLUT1 Transporter.
    Sztandera K; Działak P; Marcinkowska M; Stańczyk M; Gorzkiewicz M; Janaszewska A; Klajnert-Maculewicz B
    Pharm Res; 2019 Jul; 36(10):140. PubMed ID: 31367876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.